BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 17126056)

  • 1. Development of recurrent pseudoseptic arthritis in a patient with rheumatoid arthritis receiving TNF-alpha blocker.
    Korkmaz C; Kaşifoğlu T
    Joint Bone Spine; 2006 Dec; 73(6):767-8. PubMed ID: 17126056
    [No Abstract]   [Full Text] [Related]  

  • 2. Listeria monocytogenes septic arthritis in a patient treated with etanercept for rheumatoid arthritis.
    Nadarajah K; Pritchard C
    J Clin Rheumatol; 2005 Apr; 11(2):120-2. PubMed ID: 16357718
    [No Abstract]   [Full Text] [Related]  

  • 3. Paradoxical psoriatic arthritis in a patient with rheumatoid arthritis treated by TNFα blocker.
    Villani AP; Weiler L; Jullien D; Chapurlat R; Confavreux C
    Joint Bone Spine; 2014 Oct; 81(5):455-6. PubMed ID: 24561024
    [No Abstract]   [Full Text] [Related]  

  • 4. Acute ocular myositis occurring under etanercept for rheumatoid arthritis.
    Couderc M; Mathieu S; Tournadre A; Dubost JJ; Soubrier M
    Joint Bone Spine; 2014 Oct; 81(5):445-6. PubMed ID: 24746476
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of type 1 diabetes in a patient treated with anti-TNF-alpha therapy for active rheumatoid arthritis.
    Tack CJ; Kleijwegt FS; Van Riel PL; Roep BO
    Diabetologia; 2009 Jul; 52(7):1442-4. PubMed ID: 19440690
    [No Abstract]   [Full Text] [Related]  

  • 6. A case of tuberculous arthritis following the use of etanercept.
    Choi SW; Ahn JJ; Hwang YT; Koh SH; Cho SD
    Korean J Intern Med; 2009 Dec; 24(4):397-401. PubMed ID: 19949742
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [TNF inhibitors for treatment of rheumatoid arthritis].
    Otomo K; Koike T
    Nihon Naika Gakkai Zasshi; 2008 Oct; 97(10):2405-12. PubMed ID: 19149036
    [No Abstract]   [Full Text] [Related]  

  • 8. Henoch Schönlein purpura following etanercept treatment of rheumatoid arthritis.
    Duffy TN; Genta M; Moll S; Martin PY; Gabay C
    Clin Exp Rheumatol; 2006; 24(2 Suppl 41):S106. PubMed ID: 16859610
    [No Abstract]   [Full Text] [Related]  

  • 9. Development of rheumatoid nodules during anti-tumor necrosis factor alpha therapy with etanercept.
    Kekow J; Welte T; Kellner U; Pap T
    Arthritis Rheum; 2002 Mar; 46(3):843-4. PubMed ID: 11920425
    [No Abstract]   [Full Text] [Related]  

  • 10. Cutaneous pseudolymphoma associated with a TNF-alpha inhibitor treatment: etanercept.
    Guis S; Schiano de Colella JM; Bonnet N; Andrac-Meyer L; Balandraud N; Mattei JP; Franck B; Roudier C; Roudier J; Berbis P
    Eur J Dermatol; 2008; 18(4):474-6. PubMed ID: 18573737
    [No Abstract]   [Full Text] [Related]  

  • 11. Viral pneumonia as a serious complication of etanercept therapy.
    Smith D; Letendre S
    Ann Intern Med; 2002 Jan; 136(2):174. PubMed ID: 11790076
    [No Abstract]   [Full Text] [Related]  

  • 12. Anti-TNF agents for rheumatoid arthritis.
    Seymour HE; Worsley A; Smith JM; Thomas SH
    Br J Clin Pharmacol; 2001 Mar; 51(3):201-8. PubMed ID: 11298065
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Etanercept-induced Wegener granulomatosis in a patient with rheumatoid arthritis.
    Broshtilova V; Iliev E; Gantcheva M
    Dermatol Ther; 2013; 26(1):73-6. PubMed ID: 23384023
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sarcoidosis: an underestimated and potentially severe side effect of anti-TNF-alpha therapy.
    Vigne C; Tebib JG; Pacheco Y; Coury F
    Joint Bone Spine; 2013 Jan; 80(1):104-7. PubMed ID: 22885144
    [No Abstract]   [Full Text] [Related]  

  • 15. Etanercept-induced necrotizing crescentic glomerulonephritis in two patients with rheumatoid arthritis.
    Kaneko K; Nanki T; Hosoya T; Mizoguchi F; Miyasaka N
    Mod Rheumatol; 2010 Dec; 20(6):632-6. PubMed ID: 20617355
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Anti-TNF alpha therapy: a risk factor for legionella infection].
    Lagier JC; Andriamanantena D; Damiano J; Dot JM; Chaudier B; Margery J
    Rev Mal Respir; 2007 Nov; 24(9):1159-60. PubMed ID: 18176398
    [No Abstract]   [Full Text] [Related]  

  • 17. Fatal streptococcal toxic shock syndrome in a patient with rheumatoid arthritis treated with etanercept.
    Uthman I; Husari A; Touma Z; Kanj SS
    Rheumatology (Oxford); 2005 Sep; 44(9):1200-1. PubMed ID: 15870144
    [No Abstract]   [Full Text] [Related]  

  • 18. Adverse reactions to TNF-alpha inhibitors in rheumatoid arthritis.
    Day R
    Lancet; 2002 Feb; 359(9306):540-1. PubMed ID: 11867103
    [No Abstract]   [Full Text] [Related]  

  • 19. Septic arthritis due to Listeria monocytogenes in a patient receiving etanercept.
    Rachapalli S; O'Daunt S
    Arthritis Rheum; 2005 Mar; 52(3):987. PubMed ID: 15751076
    [No Abstract]   [Full Text] [Related]  

  • 20. Perforating folliculitis associated with tumour necrosis factor-alpha inhibitors administered for rheumatoid arthritis.
    Gilaberte Y; Coscojuela C; Vázquez C; Roselló R; Vera J
    Br J Dermatol; 2007 Feb; 156(2):368-71. PubMed ID: 17223880
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.